RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 201 filers reported holding RECURSION PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is 0.72 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $15,732,542 | +666.9% | 2,097,672 | +919.4% | 0.01% | +400.0% |
| Q1 2024 | $2,051,517 | -8.3% | 205,769 | -9.3% | 0.00% | 0.0% |
| Q4 2023 | $2,236,967 | +38.2% | 226,873 | +7.2% | 0.00% | 0.0% |
| Q3 2023 | $1,618,557 | +110.5% | 211,576 | +83.5% | 0.00% | – |
| Q2 2023 | $768,904 | 0.0% | 115,278 | 0.0% | 0.00% | – |
| Q1 2023 | $768,904 | -6.7% | 115,278 | +7.8% | 0.00% | – |
| Q4 2022 | $824,438 | -99.9% | 106,931 | +39.1% | 0.00% | – |
| Q3 2022 | $817,993,000 | +95.3% | 76,879 | +49.4% | 0.00% | – |
| Q2 2022 | $418,827,000 | +21.4% | 51,453 | +6.8% | 0.00% | – |
| Q1 2022 | $345,069,000 | -43.2% | 48,194 | +35.9% | 0.00% | – |
| Q4 2021 | $607,310,000 | – | 35,453 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Sigma Ventures, LP | 903,400 | $9,612,000 | 100.00% |
| Obvious Management Services, L.L.C. | 3,985,087 | $42,401,000 | 100.00% |
| DCVC Opportunity Fund II GP, LLC | 3,951,141 | $42,040,000 | 54.37% |
| Data Collective IV GP, LLC | 5,941,120 | $63,214,000 | 49.97% |
| MIC Capital Management UK LLP | 8,451,758 | $89,927,000 | 16.21% |
| MV Management XI, L.L.C. | 1,971,908 | $20,981,000 | 15.20% |
| ArchPoint Investors | 1,116,126 | $11,876,000 | 4.85% |
| HARVARD MANAGEMENT CO INC | 1,509,254 | $16,058,000 | 2.00% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,251,971 | $23,961,000 | 1.00% |
| Duquesne Family Office | 1,385,950 | $14,747,000 | 0.84% |